Updated:
Synthesis Capital (Boston)
Synthesis Capital is a Boston-based venture capital firm formerly known as Advent Healthcare Ventures. The firm focuses its investment strategy exclusively on...
Synthesis Capital (Boston)
Synthesis Capital is a Boston-based venture capital firm formerly known as Advent Healthcare Ventures. The firm focuses its investment strategy exclusively on the healthcare sector. Within this industry, Synthesis Capital targets companies operating in biotech, pharmaceuticals, medical devices, and healthcare services. As a venture capital investor, it seeks to fund innovative businesses driving advancements in medical technology and care delivery. The firm is headquartered in Boston, United States, positioning it within a prominent hub for life sciences and healthcare innovation. Through its targeted approach, Synthesis Capital supports the development and growth of healthcare-focused companies.
General information
Firm type
Venture Capital
Location
Country
United States
City
Boston
Corporate office
Boston, United States
Sector focus
Frequently asked questions
What is Synthesis Capital's investment focus?
Synthesis Capital invests in the healthcare sector, specifically targeting biotech, pharma, medical device, and healthcare services companies.
Where is Synthesis Capital headquartered?
The firm is headquartered in Boston, United States.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: